Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
Tamás Biernacki, Zsófia Kokas, Dániel Sandi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3383-3383
Open Access | Times Cited: 24

Showing 24 citing articles:

Editorial of Special Issue ‘Dissecting Neurological and Neuropsychiatric Diseases: Neurodegeneration and Neuroprotection’
Masaru Tanaka, László Vécsei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6991-6991
Open Access | Times Cited: 61
Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?
Jelle Y. Broos, Rianne T. M. van der Burgt, Julia Konings, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9
The role of plasma cortisol in dementia, epilepsy, and multiple sclerosis: A Mendelian randomization study
Haiqi Li, Kaili Chen, Le Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
The role of the “gut microbiota-mitochondria” crosstalk in the pathogenesis of multiple sclerosis
Huan Tian, Dunbing Huang, Jiaqi Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
“Advances in biomarker discovery and diagnostics for alzheimer’s disease”
Vandana Bhatia, Abhimanyu Chandel, Yavnika Minhas, et al.
Neurological Sciences (2025)
Closed Access
Treatment-resistant inflammatory demyelinating pseudotumor with Marburg-like features: A narrative review-based treatment approach
Mohammad Amin Najafi, Shakiba Houshi, Payam Riahi, et al.
Journal of Research in Medical Sciences (2025) Vol. 30, Iss. 1
Open Access
Fluid-based biomarkers for neurodegenerative diseases
Yongliang Cao, Yifei Xu, Meiqun Cao, et al.
Ageing Research Reviews (2025), pp. 102739-102739
Open Access
Temporal relationship between neurofilament light chain and cytokines involved in T helper-17 lymphocyte signaling in the blood of experimental autoimmune encephalomyelitis mice
Rashmi Koul, Wei Lü, Teobaldo E. Torres, et al.
Multiple Sclerosis and Related Disorders (2025), pp. 106463-106463
Closed Access
A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
Anna Pafiti, George Krashias, John S. Tzartos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10787-10787
Open Access | Times Cited: 7
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 6
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients
Giovanna Cardiero, Daniela De Palma, Martina Vano, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2554-2554
Open Access | Times Cited: 9
MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study
Aurora Zanghì, Virginia Manuti, Gaetano Serviddio, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Retrospective Analysis of Blood Biomarkers of Neurological Injury in Human Cases of Viral Infection and Bacterial Sepsis
Maggie L. Bartlett, Heather Goux, Linwood Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Advances in nanotechnology versus stem cell therapy for the theranostics of multiple sclerosis disease
Amirmasoud Rayati Damavandi, Omid Mirmosayyeb, Narges Ebrahimi, et al.
Applied Nanoscience (2022) Vol. 13, Iss. 6, pp. 4043-4073
Closed Access | Times Cited: 7
CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS
Andrea Burgetová, Petr Dušek, Tomáš Uher, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10048-10048
Open Access | Times Cited: 3
Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke
Xiaoting Zhang, Huixian Wang, Li Li, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 4
Symbol Digit Modalities Test in progressive multiple sclerosis
Bartosz Gajewski, Iwona Karlińska, Mariusz Stasiołek
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 3, pp. 221-232
Open Access
Angiogenesis biomarkers discriminate multiple sclerosis phenotypes
Heather Yong, Cláudia Silva, Nicholas J. Batty, et al.
Research Square (Research Square) (2024)
Open Access
Mineralocorticoid Receptor Signaling in Peripheral Blood Cells in Patients with Multiple Sclerosis
Franziska Küstermann, Kathy Busse, Johannes Orthgieß, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8883-8883
Open Access
The cost-of-illness of multiple sclerosis in Jordan
Ibrahim Alabbadi, Sara Al-Ajlouny, Yazan Alsoud, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024)
Closed Access
Características clínicas y demográficas de los sujetos con esclerosis múltiple en un instituto de rehabilitación en la Ciudad de Buenos Aires
Rocío Zanazzi, Jennifer Daiana Bentos, María Antonela Zanier, et al.
Argentinian Journal of Respiratory & Physical Therapy (2024) Vol. 6, Iss. 3
Open Access
Glial fibrillary acidic protein: is there a relationship with the course of multiple sclerosis and traumatic brain injury before the onset of multiple sclerosis?
E Yu Elchaninova, A I Afanas'eva, И. В. Смагина, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 10, pp. 80-80
Closed Access
Measuring Disease Progression in Multiple Sclerosis Clinical Drug Trials and Impact on Future Patient Care
Floriana De Angelis, Riccardo Nistri, Sarah Wright
CNS Drugs (2024)
Closed Access
The Role of Sleep in Multiple Sclerosis
Susanna Cordone, Valentina Alfonsi, Luigi De Gennaro
(2023)
Open Access | Times Cited: 1
Laboratory biomarkers for multiple sclerosis and their role in clinical practice
Ieva Navickaitė, Gintarė Žemgulytė, Renata Balnytė
Neurologijos seminarai (2023) Vol. 27, Iss. 95, pp. 34-40
Open Access
Page 1

Scroll to top